The results from PDX models and tumor-derived cell lines showed consistency, indicating that knocking down NRG1 or using PI3K/AKT inhibitors inhibited cell proliferation and migration and promoted apoptosis, while the use of PI3K/AKT activators accelerated cell proliferation, increased migration ability, and decreased apoptosis rate. The gene discussed is NRG1; the disease is neoplasm.